Mending Mouths: Rebuilding Jawbones With Stem Cells - NewsChannel5.com | Nashville News, Weather & Sports

Mending Mouths: Rebuilding Jawbones With Stem Cells

Posted: Updated:

MIAMI, Fla. (Ivanhoe Newswire) - Whether it's destroyed by a bullet, disease, or a bad infection, doctors have a new way to rebuild bone in the face.  Now, stem cells are giving gunshot victims, cancer patients, and others new hope.

Oral surgeon Dr. Robert Marx examined Ramsey Hasan's new mouth.

"A wisdom tooth extraction went bad. I lost a significant portion of my jaw," Ramsey Hasan, who had part of his jaw removed, told Ivanhoe.

Dr. Marx used a surgical technique, called in-situ tissue engineering, to grow Ramsey a new jaw. Stem cells are harvested from the hip bone during reconstructive surgery. Cadaver bone and a special protein called BMP help those stem cells grow bone.

"In here are the stem cells that the BMP is going to signal to form bone," Robert E. Marx, DDS, Professor of Surgery and Chief, Oral, and Maxillofacial Surgery at the University of Miami Miller School of Medicine, told Ivanhoe.

 The components are secured with a titanium plate.

"In six months the bone is absolutely normal. Any of the cadaver bone is dissolved and replaced by the patient's own bone, stimulated by the BM-, and actually produced by the bone marrow," Dr. Marx said.

Now, Ramsey's healed and he's happy with the results.

"I now have a healthy gum, a healthy jaw, which is most important, and some fake teeth that don't feel fake," Ramsey explained.

Dr. Marx helped pioneer this stem cell procedure at the University of Miami. Right now, he is the only one performing it, but he is currently teaching the technique to other doctors around the country. Traditionally, bone is taken from the hip or leg and surgically implanted into the jaw. That means a longer hospital stay and longer overall recovery time.

RESEARCH SUMMARY

BACKGROUND:  Maxillofacial bone grafting and bone harvesting developed to the scientific level during WWI.  The development of radical surgery to treat oral cancers began close to 1906.  That effort along with the increase in war-related maxillofacial defects began in 1914.  The U.S. Army Medical Corps and the U.S. Army Dental Corps began with a block graft harvest from the lacteral tibia with a reported success rate of 64.5 percent.  During 1918 and 1941, anesthesia became more reliable.  The practice of bone harvesting, mostly from the ribs and iliac crest, was utilized in WWII related jaw reconstructions.  During WWII one-piece iliac block grafts were used 81 percent of the time, ribs 15 percent, one—piece tibia grafts 2 percent, and chip grafts 1 percent.  In 1944, iliac cancellous bone chips were introduced.  After WWII, tumor and civilian trauma were the main indications for mandibular reconstruction and cancellous marrow grafts were the most common.  This type of grafting has been popularized in the 1990s and early 2000.  Now, free microvascular transfers of the fibula are often used today by nondental surgeons to reconstruct defects of the mandible.  Recombinant human bone morphogenetic protein (rhBMP) has shown significant bone regeneration capabilities in maxillofacial and oral bone defects.  (Source: Marx, Robert E., Atlas of Oral and Extraoral Bone Harvesting)

HARVESTED BONE:  When a bone graft is harvested, there is a period of time before it is placed into the recipient site.  It is recommended to minimize the out of body time, but sometimes it can extend up to two hours.  The principle of autogenous bone harvesting is to transplant viable osteocompetent cells along with a matrix that contains a signal for bone regeneration.  It is necessary to maintain the viability of the grafts.  Studies have shown that room-temperature saline preserves more than 95% of graft cell viability for at least four hours.  Because autogenous osteocompetent cells and bone marrow stem cells are hardy, they will survive to regenerate bone in most cases unless they are destroyed during the time between harvest and placement.  The most common cause of cell viability is contact with sterile distilled water.  (Source: Marx, Robert E., Atlas of Oral and Extraoral Bone Harvesting)

NEW TECHNOLOGY:  Recombinant human bone morphogenetic protein-2/acellular collagen sponge was FDA approved for orthopedic lumbar spinal fusions, open tibial fractures, oral and maxillofacial sinus floor augmentations and alveolar ridge preservations.  It is an alternative to autogenous bone grafting without the morbidity of bone harvesting.  It regenerates new bone on its own.  The bound BMP in the acellular collagen sponge is chemotactic to stem cells and preosteoblasts.  These cells will migrate into the sponge and undergo proliferation and differentiation into osteoblasts, which will then synthesize osteoid.  Once this process is complete, the osteoid will undergo the standard remodeling cycle of bone to a mature ossicle in six months.  The production of rhBMP-2 begins with restricted enzymes, which is the BMP-2 gene from chromosome 20 in the human genome.  This gene is transferred into a bacterial plasmid.  Then it is transfected into a chromosome in Chinese hamster ovary cells (CHO) and cultured to increase the numbers.  The CHO cells will produce hamster proteins, but also one unique human protein called BMP-2.  It is separated to produce a purely human protein free of bacteria or animal proteins and in high concentrations to regenerate bone in humans.  (Source: Marx, Robert E., Atlas of Oral and Extraoral Bone Harvesting)

INTERVIEW

Robert E. Marx, DDS, Professor of Surgery and Chief, Oral and Maxillofacial Surgery at the University of Miami Miller School of Medicine, talks about stem cells for the jawbone.

Now you're able to create bone instead of using the patient's own bone to create a jaw bone, is that what's happening?

Dr. Marx: Yes. It's called In-situ tissue engineering. We're able to regenerate large portions of missing bone; at least the jaw bone and not taking any bone from the patients themselves using three things: stem cells aspirated from their bone marrow, recombinant human bone morphogenetic protein (BMP), and cadaver crushed bone, which is sterile from the University of Miami Tissue Bank.

So, you put all of this in with a metal plate in the jaw and it turns into hardened bone in six months?

Dr. Marx: In six months the bone is absolutely normal. Any of the cadaver bone has been dissolved and replaced by the patient's own bone, stimulated by the BMP, and actually produced by the bone marrow. The metal plate that's internal stays there as a form of rigid fixation and holds the bone still during the healing process.

How much time does this shave off of a patient's stay in the hospital from the old method to the new method?

Dr. Marx: It shaves off at least three days, maybe four. In the standard use of open hip grafting, patients are in the hospital for about four days. Another alternative is to take a leg bone called the fibula. Those patients are in the hospital ten days and usually three days in the intensive care unit. With In-situ tissue engineering, the patients are out the next day.

Tell me about Ramsey, what happened to his jawbone?

Dr. Marx: Ramsey suffered complications from a wisdom tooth removal. He developed a pretty serious infection. It progressed to weaken his jaw; then his jaw finally broke and resulted in a significant amount of dead bone that we had to remove.

And how did he respond to the therapy?

Dr. Marx: He responded perfectly. He was a good patient and his otherwise general body health helped him through difficult times. Because we had to remove about four or five inches of his jawbone and replace it, we did it in two separate surgeries. The first one was to eradicate the infection. The second one was to rebuild the bone with this In-situ tissue engineering. Then he had a routine dental implant placement placed. He had not only his bone placed back, but also his teeth placed back through dental implants.

What is this used for, tumors and broken jaws?

Dr. Marx:  It can be used in trauma. We've done this for gunshot wounds, benign tumors, and for individuals who have had malignant tumors removed as long as they did not have active cancer. This combination works in almost all patients. Right now we're trying to make it work in the most difficult group and that is the radiated patients, but we are still in research format.

When you take the bone marrow, is it taken at the same time that you replace it into the jaw?

Dr. Marx:  Yes. That's the large advantage of it. It's the patient's own bone marrow and it's essentially at the same time. There is no delay. There's also no risk of infection by transferring it into a culture plate to an outside institution. It's very practical and has proven now to be very successful.

Did anybody fund this study?

Dr. Marx: No one funded this study. We do have a research chair that funded this study, but this is not beholden to any company at all. It is internally funded through the University of Miami.

Are you directly or indirectly compensated by the manufacturer for your involvement in this procedure?

Dr. Marx: No, not this particular procedure. I have been a paid consultant to these companies for the FDA required research, but this is not that part. These are our own independent non-funded studies.

Will your hospital or organization benefit financially by this procedure?

Dr. Marx:  I think they will only because they have less cost. It's a shorter operation, less hospital time for a very good reason, and less complications. So, there is less redo. In the long run it saves a lot of their expenses.

What concerns do other doctors have as to why they are not using this procedure?

Dr. Marx: This is a relatively new technique that came from all of our research.  We have been developing books.  Because it is new, not everyone has been trained in this. So, we are training fellows and residents each year.

FOR MORE INFORMATION, PLEASE CONTACT:

Robert E. Marx, DDS
Professor of Surgery and Chief
Oral and Maxillofacial Surgery
University of Miami Miller School of Medicine
(305) 256-5270
rmarx@med.miami.edu 

  • Medical News HeadlinesMedical News HeadlinesMore>>

  • Migraine Relief: Stopping Pain & Relieving Pressure

    Migraine Relief: Stopping Pain & Relieving Pressure

    Friday, April 18 2014 5:15 PM EDT2014-04-18 21:15:06 GMT
    Meredith Messerli is thankful she can study without pain. The college freshman spent two years of her life battling severe migraines.more>>
    Meredith Messerli is thankful she can study without pain. The college freshman spent two years of her life battling severe migraines.more>>
  • Hope For Lanie: Curing SMA

    Hope For Lanie: Curing SMA

    Thursday, April 17 2014 5:15 PM EDT2014-04-17 21:15:09 GMT
    SMA attacks the body's motor neurons and causes paralysis. There is no cure, but for the first time doctors are studying an experimental therapy that targets more than just symptoms.more>>
    SMA attacks the body's motor neurons and causes paralysis. There is no cure for SMA but for the first time doctors are studying an experimental therapy that targets more than just symptoms, it targets mutated SMN genes, which are responsible for SMA.more>>
  • Washing Lungs & Breathing Better

    Washing Lungs & Breathing Better

    Wednesday, April 16 2014 5:15 PM EDT2014-04-16 21:15:09 GMT
    Imagine not being able to breathe without struggling: every breath you take is work; every breath you take could be your last. That was the case for one man who became dependent on an oxygen tank to stay alive.more>>
    Imagine not being able to breathe without struggling: every breath you take is work; every breath you take could be your last. That was the case for one man who became dependent on an oxygen tank to stay alive.more>>
  • Ocular Melanoma: Saving Lives, Saving Eyes

    Ocular Melanoma: Saving Lives, Saving Eyes

    Friday, April 11 2014 5:15 PM EDT2014-04-11 21:15:07 GMT
    Ocular melanoma, also called uveal melanoma, is a rare type of melanoma that targets the eye. It can be a deadly if it isn't spotted early enough. Now, there's a way to treat patients that's saving lives and saving eyes.more>>
    Ocular melanoma, also called uveal melanoma, is a type of melanoma that targets the eye. It affects about 2,000 people a year in the United States. Although rare – it can be a deadly if it isn't spotted early enough. Now, there's a way to treat patients that's saving lives and saving eyes.more>>
  • Memory Palace: Coping With Chemo Brain

    Memory Palace: Coping With Chemo Brain

    Thursday, April 10 2014 5:15 PM EDT2014-04-10 21:15:09 GMT
    More than 13 million Americans are living with some form of cancer. Harsh treatments like chemo and radiation save lives, but they will also change lives. Now, many cancer survivors are learning how to cope with chemo brain.more>>
    More than 13 million Americans are living with some form of cancer. Harsh treatments like chemo and radiation save lives, but they will also change lives. Now, many cancer survivors are learning how to cope with chemo brain.more>>
  • Pedaling For A Cure

    Pedaling For A Cure

    Wednesday, April 9 2014 5:15 PM EDT2014-04-09 21:15:09 GMT
    Five years ago, Leslie Trudeau's world came crashing down. At just 22 years old, her son Taylor lost his battle with leukemia. That's why Trudeau is pedaling for a cure.more>>
    Five years ago, Leslie Trudeau's world came crashing down. At just 22 years old, her son Taylor lost his battle with leukemia. That's why Trudeau is pedaling for a cure.more>>
  • Bringing Hearts Back To Life: New Improved Defibrillator

    Bringing Hearts Back To Life: New Improved Defibrillator

    Tuesday, April 8 2014 5:15 PM EDT2014-04-08 21:15:13 GMT
    CPR and a portable defibrillator helped keep Eric Robinson alive after he went into cardiac arrest. And now a newly FDA approved Biotronik implantable cardiac defibrillator, or ICD, constantly monitors his heart.more>>
    A year ago, while jamming with his son's band, Eric Robinson went into cardiac arrest. CPR and a portable defibrillator helped keep Robinson alive. And now a newly FDA approved Biotronik implantable cardiac defibrillator, or ICD, constantly monitors his heart.more>>
  • Helping High Risk Hearts

    Helping High Risk Hearts

    Monday, April 7 2014 5:15 PM EDT2014-04-07 21:15:09 GMT
    Ironing is not exactly Barbara Roy's favorite activity, but it's something she's glad she can do again. Her doctor diagnosed her with severe aortic stenosis.more>>
    Ironing is not exactly Barbara Roy's favorite activity, but it's something she's glad she can do again. Her doctor diagnosed her with severe aortic stenosis.more>>
  • Hernias In Newborns: Lincoln's Story

    Hernias In Newborns: Lincoln's Story

    Friday, April 4 2014 5:15 PM EDT2014-04-04 21:15:07 GMT
    Congenital diaphragmatic hernias occur in about one in every 2,000 births. They can be deadly, but now doctors are using a more aggressive treatment approach.more>>
    Congenital diaphragmatic hernias occur in about one in every 2,000 births. They can be deadly, but now doctors are using a more aggressive treatment approach.more>>
  • Predicting Bad Hearts

    Predicting Bad Hearts

    Thursday, April 3 2014 5:15 PM EDT2014-04-03 21:15:09 GMT
    Every year, more than 700,000 Americans have a heart attack. Now, researchers at Baylor Research Institute at Dallas have uncovered a biomarker that may help them spot the disease sooner.more>>
    Every year, more than 700,000 Americans have a heart attack. And 600,000 die of heart disease. Now, researchers at Baylor Research Institute at Dallas have uncovered a biomarker that may help them spot the disease sooner; and they did it by pure accident.more>>
Powered by WorldNow
Powered by WorldNow
All content © Copyright 2000 - 2014 NewsChannel 5 (WTVF-TV) and WorldNow. All Rights Reserved.
For more information on this site, please read our Privacy Policy and Terms of Service.